I think many have concerns over side-effects. Expect an announcement detailing further (expensive) clinical testing.
Hold steady, and you will be rewarded in the long term. We should see a short-term correction, due to the unsustainable 300 million market cap. Don't sell - it will make things worse.
- Forums
- ASX - By Stock
- SLA
- ropren concerns cause further delays
ropren concerns cause further delays
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online